Guggenheim analyst Subbu Nambi lowered the firm’s price target on Tempus AI (TEM) to $60 from $95 and keeps a Buy rating on the shares. The firm adjusted models and forecasts for select companies in its diagnostics and life science tools coverage to reflect recent updates from the companies after meetings with management teams.
Claim 55% Off TipRanks
Forget margin or options. Here's how the pros trade TEMPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
- Cathie Wood Rotates $84M Out of Meta, Nvidia, Chip Stocks – Here’s Why
- Cathie Wood’s ARK Investment buys 61K shares of Tempus AI today
- Cathie Wood’s ARK Investment buys 85K shares of Tempus AI today
- Tempus AI enters collaboration with Daiichi Sankyo
- Tempus AI, Blood Cancer United announce strategic collaboration